The Exovita Story
Exovita Biosciences, Inc., is a New Mexico-based biotech startup company that is developing potentially transformative, exosome-based cancer therapeutics that harness the body’s natural defenses to fight cancer.
We have licensed patent-pending technology for our cancer-fighting drug candidate developed at the University of New Mexico. Our initial focus is breast cancer, with the idea of leveraging the technology and resulting therapeutics to other forms of cancer such as pancreatic, colon and prostate. We believe Exovita’s technology is the potential foundation for more effective cancer treatments.
Partners supporting Exovita include the New Mexico Startup Factory, the University of New Mexico Health Sciences Center, STC.UNM, and Peacock Myers, PC.
Kristina Trujillo, PhD
Principal Investigator, UNM
Dr. Trujillo is a research assistant professor at the University of New Mexico Health Sciences Center. Her research focus is cancer biology, cancer metabolism and breast cancer. She is a grantee of the National Cancer Institute and American Cancer Society.
CEO + Board Chair
Mr. Chavez is a serial entrepreneur, private investor, founder of the New Mexico Startup Factory, president of the New Mexico Angels, and managing director of Phase One Ventures’ biotech and nanotechnology fund.
Mr. Laslie has more than 35 years of experience in international drug development and commercialization at Pfizer, Sanofi, Otsuka America, and Myriad. He currently is CEO of Zocere, Inc., developing neuroprotectant drugs.
Mr. Trom is the CEO of Lovelace Pharmacy, a division of Lovelace Health System. A pharmacist by training, he has 30 years of experience managing pharmacy operations for national retail chains, including CVS and Albertsons.
Candice Lee Owens
Ms. Owens is the founder and principal of The Owens Law Firm, a boutique business law firm with offices in Santa Fe and Albuquerque, NM. Previously, she was a partner at Sommer Udall Sutin Law Firm and practiced at Cooley LP in Palo Alto, Calif.